# GSK commits $30 billion to US R&D and factory expansion

GSK announced it will invest $30 billion in the United States over the next five years, including a new factory in Pennsylvania for cancer drugs. The investment is expected to create thousands of jobs.

- Type: Investment
- Announced: 2025-09-17
- Where: Pennsylvania, United States
- Value: $30.0B
- Status: announced
- Products: cancer drugs
- Sectors: [Specialty Chemicals](https://endata.com/sectors/specialty-chemicals.md)

## Companies

- [GSK](https://endata.com/companies/24071.md)

## Sources

- [reuters.com](https://www.reuters.com/business/healthcare-pharmaceuticals/gsk-commits-30-billion-us-research-development-factory-expansion-trump-visits-uk-2025-09-16/), 2025-09-16: "Drugmaker GSK said Wednesday it would invest $30 billion in the United States over the next five years, including a new factory in Pennsylvania for cancer drugs."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.